Trial intelligence / Profile preview

Phentolamine Mesylate Injection for Reversal of Dental Local Anesthesia

CTR20200182Phase 2Completed

Sponsor
Furikangzheng Medical Technology
Start
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of phentolamine, sponsored by Furikangzheng Medical Technology. Started Feb 2020; status: completed.

02

Drugs

phentolamine

Beyond the preview

Go deeper on CTR20200182.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20200182.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call